Company · CIK 0001001233 · SIC 2836 — Biological Products, (No Diagnostic Substances) · OTC

SANGAMO THERAPEUTICS, INC · SGMO

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $48.0M · 10sales $93.5M · 90net −$45.5M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jun 16, 2014 GForm 5 →	Jan 16, 2015, 8:23 pm EST	Edward O Lanphier IIPresident & CEO, Director	415,500	—	—	1,189,021	—	plan?
Jun 5, 2014 SForm 4 →	Feb 18, 2015, 9:54 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	1,037,230	$14.36	$14,892,135	1,829,426	−36.2%	plan? late
May 8, 2014 SForm 4 →	Feb 18, 2015, 9:53 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	2,028,531	$13.18	$26,743,790	2,829,441	−41.8%	plan? late
May 7, 2014 PForm 4 →	Feb 18, 2015, 9:53 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	35,736	$12.09	$431,870	4,857,972	+0.74%	plan? late
Apr 9, 2014 SForm 4 →	Feb 18, 2015, 9:52 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	450,893	$15.05	$6,786,112	4,409,328	−9.28%	plan? late
Apr 3, 2014 PForm 4 →	Feb 18, 2015, 9:52 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	1,205,929	$14.67	$17,694,558	4,822,236	+33.3%	plan? late
Mar 7, 2014 PForm 4 →	Feb 18, 2015, 9:51 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	1,130,387	$19.83	$22,410,076	4,317,200	+35.5%	plan? late
Mar 6, 2014 SForm 4 →	Feb 18, 2015, 9:51 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	536,771	$21.05	$11,300,356	4,067,200	−11.7%	plan? late
Feb 6, 2014 SForm 4 →	Feb 18, 2015, 9:49 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	535,613	$21.11	$11,309,099	3,683,000	−12.7%	plan? late
Feb 5, 2014 PForm 4 →	Feb 18, 2015, 9:49 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	326,195	$19.78	$6,451,357	3,683,000	+9.72%	plan? late
Jan 9, 2014 SForm 4 →	Feb 18, 2015, 6:38 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	72,440	$18.35	$1,329,365	3,970,562	−1.79%	plan? late
Dec 12, 2013 PForm 4 →	Feb 18, 2015, 6:38 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	14,640	$12.09	$176,992	4,043,002	+0.36%	plan? late
Jul 17, 2013 SForm 4 →	Feb 18, 2015, 6:37 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	817,444	$9.78	$7,996,009	3,118,218	−20.8%	plan? late
Jul 17, 2013 PForm 4 →	Feb 18, 2015, 6:37 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	19,200	$9.79	$187,895	3,645,703	+0.53%	plan? late

Reported at this company — derivatives (options, RSUs, warrants)

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Jun 1, 2015 MForm 4 →	Jun 3, 9:06 pm EDT	Philip D GregorySVP of Research & CSO	15,000	—	—	24,172	—
May 15, 2015 MForm 4 →	May 19, 5:26 pm EDT	Edward O Lanphier IIPresident & CEO, Director	25,000	—	—	75,000	—
May 11, 2015 MForm 4 →	May 13, 4:40 pm EDT	Henry Ward WolffExec VP & CFO	10,000	—	—	132,000	—
May 5, 2015 MForm 4 →	May 5, 7:26 pm EDT	Dale G AndoVP, Therapeutic Dev. & CMO	15,000	—	—	65,798	—
May 4, 2015 MForm 4 →	May 5, 7:23 pm EDT	William R RingoDirector	3,000	—	—	33,200	—
May 1, 2015 MForm 4 →	May 5, 7:05 pm EDT	Philip D GregorySVP of Research & CSO	15,000	—	—	31,172	—
Apr 15, 2015 MForm 4 →	Apr 17, 7:03 pm EDT	Edward O Lanphier IIPresident & CEO, Director	25,000	—	—	100,000	—
Apr 10, 2015 MForm 4 →	Apr 14, 7:03 pm EDT	Henry Ward WolffExec VP & CFO	10,000	—	—	142,000	—
Apr 6, 2015 MForm 4 →	Apr 8, 7:06 pm EDT	Dale G AndoVP, Therapeutic Dev. & CMO	15,000	—	—	80,798	—
Apr 6, 2015 MForm 4 →	Apr 8, 7:05 pm EDT	William R RingoDirector	2,200	—	—	1,200	—
Apr 1, 2015 MForm 4 →	Apr 3, 7:53 pm EDT	Philip D GregorySVP of Research & CSO	15,000	—	—	38,172	—
Mar 19, 2015 MForm 4 →	Mar 20, 7:28 pm EDT	Henry Ward WolffExec VP & CFO	10,000	—	—	251,972	—
Mar 16, 2015 MForm 4 →	Mar 18, 8:02 pm EDT	Edward O Lanphier IIPresident & CEO, Director	25,000	—	—	125,000	—
Mar 10, 2015 MForm 4 →	Mar 12, 8:09 pm EDT	Henry Ward WolffExec VP & CFO	10,000	—	—	152,000	—
Mar 5, 2015 MForm 4 →	Mar 6, 6:51 pm EST	Steven J MentoDirector	10,000	—	—	0	—
Mar 5, 2015 MForm 4 →	Mar 6, 6:49 pm EST	Dale G AndoVP, Therapeutic Dev. & CMO	15,000	—	—	95,798	—
Mar 4, 2015 MForm 4 →	Mar 6, 7:04 pm EST	Henry Ward WolffExec VP & CFO	10,000	—	—	261,972	—
Mar 3, 2015 MForm 4 →	Mar 4, 8:06 pm EST	William R RingoDirector	2,200	—	—	3,400	—
Mar 2, 2015 MForm 4 →	Mar 4, 8:04 pm EST	Philip D GregorySVP of Research & CSO	15,000	—	—	45,172	—
Feb 17, 2015 MForm 4 →	Feb 19, 8:05 pm EST	Edward O Lanphier IIPresident & CEO, Director	25,000	—	—	150,000	—
Feb 12, 2015 MForm 4 →	Feb 13, 7:45 pm EST	Saira RamasastryDirector	10,000	—	—	14,450	—
Feb 10, 2015 MForm 4 →	Feb 12, 8:14 pm EST	Henry Ward WolffExec VP & CFO	10,000	—	—	162,000	—
Feb 5, 2015 MForm 4 →	Feb 6, 7:50 pm EST	Dale G AndoVP, Therapeutic Dev. & CMO	15,000	—	—	110,798	—
Feb 3, 2015 MForm 4 →	Feb 5, 8:19 pm EST	William R RingoDirector	2,200	—	—	5,600	—
Feb 2, 2015 MForm 4 →	Feb 4, 7:31 pm EST	Philip D GregorySVP of Research & CSO	15,000	—	—	48,172	—
Jan 15, 2015 MForm 4 →	Jan 16, 8:20 pm EST	Edward O Lanphier IIPresident & CEO, Director	25,000	—	—	175,000	—
Jan 12, 2015 MForm 4 →	Jan 14, 7:02 pm EST	Henry Ward WolffExec VP & CFO	10,000	—	—	172,000	—
Jan 5, 2015 MForm 4 →	Jan 6, 7:27 pm EST	William R RingoDirector	2,200	—	—	7,800	—
Jan 5, 2015 MForm 4 →	Jan 6, 7:26 pm EST	John William LarsonDirector	15,000	—	—	0	—
Jan 5, 2015 MForm 4 →	Jan 6, 7:24 pm EST	Dale G AndoVP, Therapeutic Dev. & CMO	1,500	—	—	11,798	—
Jan 2, 2015 MForm 4 →	Jan 6, 7:25 pm EST	Philip D GregorySVP, Research & CSO	15,000	—	—	78,000	—
Jan 29, 2014 PSForm 4 →	Feb 18, 2015, 9:49 pm EST	RA CAPITAL MANAGEMENT, LLC +2Other	33,100	$4.63	$153,088	8,275	—	late